Authors: Fakhrai, H Gramatikova, S Safaei, R

Citation: H. Fakhrai et al., Downregulation of transforming growth factor beta as therapeutic approach for brain tumors, BRAIN TUMOR IMMUNOTHERAPY, 2001, pp. 289-305

Authors: Sobol, RE Shawler, DL Carson, C Van Beveren, C Mercola, D Fakhrai, H Garrett, MA Barone, R Goldfarb, P Bartholomew, RM Brostoff, S Carlo, DJ Royston, I Gold, DP

Citation: Re. Sobol et al., Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: A phase I study, CLIN CANC R, 5(9), 1999, pp. 2359-2365

Authors: Karimi-Busheri, F Daly, G Robins, P Canas, B Pappin, DJC Sgouros, J Miller, GG Fakhrai, H Davis, EM Le Beau, MM Weinfeld, M

Citation: F. Karimi-busheri et al., Molecular characterization of a human DNA kinase, J BIOL CHEM, 274(34), 1999, pp. 24187-24194

Authors: Liau, LM Fakhrai, H Black, KL

Citation: Lm. Liau et al., Prolonged survival of rats with intracranial C6 gliomas by treatment with TGF-beta antisense gene, NEUROL RES, 20(8), 1998, pp. 742-747

Authors: Dorigo, O Shawler, DL Royston, I Sobol, RE Berek, JS Fakhrai, H

Citation: O. Dorigo et al., Combination of transforming growth factor beta antisense and interleukin-2gene therapy in the murine ovarian teratoma model, GYNECOL ONC, 71(2), 1998, pp. 204-210